Web Analytics Made Easy - StatCounter

Levofloxacin Infusion Tenders

Get complete information related to latest Levofloxacin Infusion Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Levofloxacin Infusion Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Levofloxacin Infusion Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :43370251 Due date: 19 Jan, 202619 Jan, 2026 NA
Tender For supply of biodegradable polymer coated cobalt chromium sirolimus drug eluting stent system with ultrathin 60 m , everolimus drug elluting stent of 50 micron strut thickness with biodegradable polymer hybrid cell d , everolimus eluting cobalt chromium thin strut drug eluting coronary stent assorted size

CTN :43298281 Due date: 07 Jan, 202607 Jan, 2026 NA
Tender For purchase of cathlab consumbkes to district hospital palakkad - coronary stents/ scaffolds, des, everolimus,fda approved platinum chromium platform, des, everolimus,fda approved platinum chromium platform poly-vinylidene fluoride-hexafluoropropylene ( pvdf-hfp)polymer, des, everolimus, fda approved platinum chromium platform, bioabsorbable polymer plga, des, everolimus, fda approved cobalt chromium platform stent length up 12 mmto 38mm, des, everolimus hypotube balloon technology, fda approved cobalt chromium platform stent length up to 48mm, des, everolimus, fda approved cto stent cobalt chromium platform, fluoropolymer ,2.25mm-4.25mm diameter, des, everolimus, only dcgi cobalt chromium platform, 50 micron strut thickness, des, everolimus, only ce approved cobalt chromium platform with 55 to 70 micron strut, des, everolimus, only dcgi cobalt chromium platform with 55 to 70 micron strut, des, everolimus, only dcgi cobalt chromium platform, des, everolimus, ce/dcgi approved with length 8mm to 52 mm & diameter of 2.00 mm to 4.50 mm.crest :6 valley to valley connectors:2. material : l605 alloy (cobalt chromium). design : open cell strut thickness : 60 mm 10 m/ strut width : struts: 65 10 m proximal shaft markers: 90 cm & 100 cm nbp: 9 atm / (rbp): 16 atm/ rbp 14atm (se-mkr)0.5mm (at both sides, proximal & distal)., des, everolimus, ce/fda/dcgi approved cobalt chromiumbiodegradable polymer, 60 micron strut with dual long z link technology and tetrinium design with cumilative drug release technology:length: 8,12,16,20,24,28,32,36,40,44,48, sizes:2,2.25,2.5,2.75,3,3.5,4,4.5, des, sirolimus, ce/fda/dcgi approved cobalt chromiumbiodegradable polymer, 60 micron strut with dual long z link technology and tetrinium design with cumilative drug release technology:length: 8,12,16,20,24,28,32,36,40,44,48, sizes:2,2.25,2.5,2.75,3,3.5,4,4.5, dcgi approved biodegradable polymer based everolimus eluting coronary stent system with differencial stent architecture of 6 crown design for 2 - 2.75 mm , 8 crown for 3-3.5 & 10 crown design for 4-4.5 mm length : 8 mm ,13 mm.16,19,24,29,32,37,40,44,48. diameter : 2,2.25,2.5,2.75,3,3.5,4,4.5, dcgi approved des, everolimus stent systum with cobalt chromium 65 micron strut thickness size: 2.25,2.5,2.75,3,3.5,4,4.5 length: 8 to 48 mm, des , evorolimus l 605 cobalt chromium, biodegradable polymer, dcgi approved, 60 micron struts with open & closed design,3 m coating thickness size 2.25 -5 mm ,length -8-48 mm, des, everolimus, only dcgi cobalt chromium platform, 63 micron strut thickness, des, biolimus, fda approvedcobalt chromium platform, des, biolimus, ce approvedcobalt chromium platform, des, biolimus, only dcgi approved cobalt chromium platform,60 micron strut, des, zotarolimus, fda approved cobalt chromium platform ,polymer type -biolinx, des, zotarolimus, ce approved cobalt chromium platform polymer type -phosphorylcholine, des, zotarolimus, only dcgi cobalt chromium platform hydrophilic polymer, des, zotarolimus eluting coronary stent system with core wire and continuous sinsoid technology, cobalt alloy, platinum iridium core,, des, sirolimus, fda approved cobalt chromium platform, des,serolimuseluting ce approved, cobalt chromium stent, des, sirolimus, only dcgi approved cobalt chromium platform, des, sirolimus, fda approved stainless steel platform, des, sirolimus, ce approved stainless steel platform, des, sirolimus, only dcgi approved stainless steel platform, des,sirolimus , 65 micron strut , hybrid design with proximal main branch segment and distal tapered side branch segment, des,sirolimus,cobalt chromium (any diameter / any length), ce approved biodegradable polymer based sirolimus eluting coronary stent system with differencial stent architecture of 6 crown design for 2 - 2.75 mm , 8 crown for 3-3.5 & 10 crown design for 4-4.5 mm length : 8 mm ,13 mm.16,19,24,29,32,37,40,44,48. diameter : 2,2.25,2.5,2.75,3,3.5,4,4.5, tapered des, sirolimus coronary stent with biodegradab

corporations/Associations/Others

CTN :43161610 Due date: 07 Jan, 202607 Jan, 2026 NA
Tender For e-tender for the procurement of specialty drugs for the year 2026-27 - acyclovir intravenous infusion ip 500 mg, acyclovir tab ip 800 mg, adenosine inj ip 3 mg/ml, alteplase inj 50 mg, amphotericin b inj ip 50 mg/ml, amphotericin b liposomal inj 50 mg, ampicillin and sulbactam for inj each vial contains ampicillin 1 g and sulbactam 0.5 g, aripiprazole tab ip 10 mg, artesunate +(sulphadoxine + pyremethamine) each combi blister pack contains; [3 tablets of artesunate (each 200 mg) and 2 tablets of sulphadoxine + pyremethamine (each 750 mg + 37.5 mg)] or [3 tablets of artesunate (each 200 mg) and 3 tablets of sulphadoxine + pyremethamine (each 500 mg + 25 mg)], artesunate inj ip 60 mg, atomoxetine tab 10 mg, atomoxetine tab 25 mg, aztreonam inj usp 1 gm, barium sulphate suspension bp/usp 95% w/v, bethanechol chloride tab bp 25 mg, botulinum toxin a inj (freeze-dried powder for injection) 50 units, botulinum toxin a inj (freeze-dried powder for injection) 100 units, caffeine citrate inj bp/usp 20 mg/ml, calcitriol tab 0.25 mcg, calcium acetate tab 667 mg, carbimazole tab ip 5 mg, cefpodoxime oral suspension ip 100 mg/5 ml, ceftazidime and avibactam inj each vial contains ceftazidime pentahydrate equivalent to ceftazidime 2 g and avibactam sodium equivalent to avibactam 0.5 g, ceftazidime for inj ip 1 gm, cefuroxime axetil tab ip 500 mg, citicoline inj ip 500 mg, clarithromycin tab ip 500 mg, clindamycin cap ip 300 mg, clindamycin gel 1%, clobetasol propionate + salicylic acid ointment 0.05% w/w + 3.00% w/w, clopidogrel+aspirin tab ip 75 mg + 75 mg, colistimethate inj ip 3 miu, cyclosporine cap ip 100 mg, dabigatran cap 110 mg, dapagliflozin tab 10 mg, dapsone tab ip 100 mg, darifenacin tab 7.5 mg, desonide lotion 0.05%, dicumarol tab 25 mg, digoxin paediatric solution ip 50 mcg/ml, disodium hydrogen citrate syrup 1.53 gm/5 ml, divalproex sodium prolonged release tab ip 500 mg, doxycycline inj 100 mg, d-penicillamine cap usp 250 mg, dutasteride cap ip 0.5 mg, dydrogesterone tab ip 10 mg, entecavir tab ip 0.5 mg, esmolol inj ip 10 mg/ml, ethamsylate inj 125 mg/ml, ethinyl oestradiol and cyproterone acetate tab 35 mcg+ 2 mg, etomidate inj usp 2 mg/ml, fexofenadine tab ip 120 mg, finasteride tab ip 5 mg, flavoxate tab ip 200 mg, fluconazole infusion bp 200 mg/100 ml, fluoxetine cap ip 10 mg, flupenthixol inj ip 20 mg/ml, fluticasone cream ip 0.05% w/w, fluticasone furoate nasal spray 27.5 mcg, fluvoxamine tab ip 100 mg, formoterol fumarate and budesonide inhaler 6 mcg + 200 mcg, fosphenytoin inj each ml contains; fosphenytoin sodium 75 mg equivalent to phenytoin sodium 50 mg, framycetin skin cream 1% w/w, gadobenate dimeglumine inj 529 mg/ml, gentamicin + clotrimazole + beclomethasone cream 0.1% + 1% + 0.025%, gliclazide tab 40 mg, hcg (human chorionic gonadotropin) inj ip 5000 iu, hepatitis b vaccine (rdna) ip 20 mcg, human albumin inj ip 20%, human normal immunoglobulin for intravenous use ip 5 gm, hyaluronidase inj ip 1500 u, hydrocortisone cream ip 1%, hydroxy progesterone caproate inj ip 250 mg/ml, isoprenaline inj ip 2 mg/ml, itraconazole tab 200 mg, ivabradine tab 5 mg, l ornithine l aspartate infusion 5 gm/10 ml, lacosamide tab 100 mg, lactulose enema 20% w/v, lamivudine tab ip 100 mg, levetiracetam inj 100 mg/ml, levetiracetam oral solution ip 100 mg/ml, levofloxacin infusion ip 500 mg, lignocaine + prilocaine cream ip 2.5% + 2.5%, lignocaine hydrochloride topical solution ip 2% w/v, lignocaine spray 10%, linezolid for oral suspension 100 mg/5 ml, mecobalamine tab 500 mcg, medroxy progesterone acetate depot inj 150 mg/ml, menotropin for injection (hmg -human menopausal gonadotropin) ip/bp 75 iu, mephentermine inj ip 30 mg/ml, methylphenidate tab 10 mg, methylprednisolone tab ip 8 mg, metoprolol inj ip 1 mg/ml, mirtazapine tab ip 15 mg, misoprostol tab ip 100 mcg, misoprostol tab ip 25 mcg, mometasone furoate cream ip 0.1% w/w, mycophenolate mofetil tab ip 500 mg, natural micronised progesterone inj 100 mg/ml, natural surfacta

CTN :43239585 Due date: 08 Jan, 202608 Jan, 2026 15.89 Lacs
Tender For supply of dept of lab sciences d d-- lcms kit for immunosuppressant drugs cyclosporin everolimus tacrolimus sirolimus compatible with waters xevo tq s micro pack of 400 tests , lcms trap column for immunosuppressant drugs cyclosporin everolimus tacrolimus sirolimus compatible with waters xevo tq s micro 1 pc , lcms analytical column for immunosuppressant drugs cyclosporin everolimus tacrolimus sirolimus compatible with waters xevo tq s micro 1 pc , lcms multilevel calibrator for immunosuppressant drugs cyclosporin everolimus tacrolimus sirolimus compatible with waters xevo tq s micro pack of 7x2 ml , lcms four level controls for immunosuppressant drugs cyclosporin everolimus tacrolimus sirolimus lyoph compatible with waters xevo tq s micro pack of 4x2x2 0 ml , lcms tuning mix for immunosuppressant drugs cyclosporin everolimus tacrolimus sirolimus compatible with waters xevo tq s micro vial of 1ml , autosampler vails with inserts 2ml for waters xevo tq s box of 96 , lcms mobile phase a for immunosuppressant drugs cyclosporin everolimus tacrolimus sirolimus compatible with waters xevo tq s micro bottle of 1000 ml , lcms mobile phase b for immunosuppressant drugs cyclosporin everolimus tacrolimus tacrolimus compatible with waters xevo tq s micro bottle of 1000 ml , lcms internal standard for immunosuppressant drugs cyclosporin everolimus tacrolimus sirolimus compatible with waters xevo tq s micro pack of 4x2 5 ml , acitonitrile lcms grade bottle of 1 ltr , pm kit for waters tq s micro , setup solution for waters xevo tq s micro vial of 1 ml ) /bid number: gem/2025/b/6938698 * /dated: 18-12-2025 & & / bid document1 / 17
 Loading, Please wait...

Connect us via What's Up